Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Constipation-predominant Irritable Bowel Syndrome (IBS-C)”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Testing effectiveness (Phase 2)Study completedNCT01714843
What this trial is testing

Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Who this might be right for
Constipation-predominant Irritable Bowel Syndrome (IBS-C)
Astellas Pharma Inc 559
Large-scale testing (Phase 3)Study completedNCT02621892
What this trial is testing

A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C

Who this might be right for
Constipation Predominant Irritable Bowel Syndrome
Ardelyx 606
Not applicableLooking for participantsNCT07094035
What this trial is testing

The Beneficial Effects on the Intestinal Function of a Food Supplement Based on an Extract of Green Tea and a Pool of Probiotics in Subjects With Irritable Bowel Syndrome With Predominance of Constipation

Who this might be right for
IBS, Constipation Predominant
Adamas Biotech S.r.l. 64
Large-scale testing (Phase 3)Ended earlyNCT00607971
What this trial is testing

Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Who this might be right for
Constipation-Predominant Irritable Bowel Syndrome
Alizyme 939
Large-scale testing (Phase 3)Study completedNCT02686138
What this trial is testing

A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C

Who this might be right for
Constipation Predominant Irritable Bowel Syndrome
Ardelyx 593
Testing effectiveness (Phase 2)Study completedNCT01027260
What this trial is testing

Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation

Who this might be right for
Irritable Bowel Syndrome
Abbott 268
Not applicableEnded earlyNCT03336034
What this trial is testing

Assessment of Responsiveness to Treatment by Experience Sampling Method

Who this might be right for
Constipation-predominant Irritable Bowel Syndrome
Maastricht University Medical Center 16
Large-scale testing (Phase 3)Study completedNCT02316899
What this trial is testing

Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
Astellas Pharma Inc 500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07431957
What this trial is testing

"Efficacy and Safety of Linaclotide in Chronic Constipation"

Who this might be right for
Chronic Idiopathic ConstipationIrritable Bowel Syndrome (IBS-C)Chronic Constipation+2 more
Md Mehedi Shahriar 90
Large-scale testing (Phase 3)Study completedNCT01923428
What this trial is testing

The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Who this might be right for
Constipation Predominant Irritable Bowel Syndrome
Ardelyx 356
Testing effectiveness (Phase 2)Study completedNCT01056107
What this trial is testing

Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients

Who this might be right for
Irritable Bowel Syndrome Constipation Predominant
Mayo Clinic 52
Large-scale testing (Phase 3)Ended earlyNCT00171431
What this trial is testing

The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)

Who this might be right for
Constipation PredominantIrritable Bowel Syndrome (IBS-C)
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)UnknownNCT06319729
What this trial is testing

A Chinese Herbal Medicine for IBS-C

Who this might be right for
Constipation-predominant Irritable Bowel Syndrome
Hong Kong Baptist University 78
Testing effectiveness (Phase 2)Ended earlyNCT02144753
What this trial is testing

Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)

Who this might be right for
Constipation-predominant IBS (IBS-C)
Nutrabiotix, LLC 120
Testing effectiveness (Phase 2)Study completedNCT01340053
What this trial is testing

Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Who this might be right for
Constipation Predominant Irritable Bowel Syndrome
Ardelyx 186
Not applicableNot Yet RecruitingNCT07388589
What this trial is testing

Soluble and Osmotic Fibre (SOLOS) Diet for Constipation

Who this might be right for
ConstipationConstipation - FunctionalConstipation Chronic Idiopathic+11 more
Singapore Institute of Technology 180
Large-scale testing (Phase 3)Study completedNCT00268879
What this trial is testing

Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)

Who this might be right for
Irritable Bowel Syndrome
Alizyme 1,821
Testing effectiveness (Phase 2)Ended earlyNCT04043455
What this trial is testing

Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)

Who this might be right for
Irritable Bowel Syndrome
Arena Pharmaceuticals 273
Early research (Phase 1)Ended earlyNCT04655599
What this trial is testing

Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Arena Pharmaceuticals 1
Not applicableNot Yet RecruitingNCT07256262
What this trial is testing

Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C)

Who this might be right for
Irritable Bowel Syndrome
Beni-Suef University 50
Next Page